<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Between 1978 and 1996 more than 7500 <z:hpo ids='HP_0002665'>lymphoma</z:hpo> transplants have been reported to the European Bone Marrow Transplantation (EBMT) <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> Registry </plain></SENT>
<SENT sid="1" pm="."><plain>This has been examined to establish the incidence of secondary <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> and to relate this to possible prognostic factors </plain></SENT>
<SENT sid="2" pm="."><plain>131 centres representing 4998 patients responded to a questionnaire </plain></SENT>
<SENT sid="3" pm="."><plain>This identified 66 patients with post transplant <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>)/<z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) </plain></SENT>
<SENT sid="4" pm="."><plain>The actuarial risk for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> at 5 years post-transplant (+/-95% CI) was 4.6% (3.1-6.8) for <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> and 3.0% (2.0-4 </plain></SENT>
<SENT sid="5" pm="."><plain>3) for non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Multivariate analysis for <z:hpo ids='HP_0000001'>all</z:hpo> patients demonstrated an effect of age at transplant, radiotherapy at conditioning, number of transplants and interval between diagnosis and transplant as risk factors </plain></SENT>
<SENT sid="7" pm="."><plain>For patients with NHL, grade of histology was important (low grade &gt; intermediate or high-grade); for <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e>, female sex was identified as a risk factor </plain></SENT>
<SENT sid="8" pm="."><plain>These findings suggest that the incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> may not be greater following an autograft than after conventional chemotherapy </plain></SENT>
</text></document>